XML 87 R69.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions - Schedule of assets acquired and liabilities assumed and allocation of consideration (Details)
$ in Thousands, € in Millions
12 Months Ended
Apr. 14, 2025
USD ($)
shares
Apr. 11, 2025
USD ($)
shares
Apr. 19, 2024
USD ($)
Feb. 02, 2024
USD ($)
Feb. 02, 2024
EUR (€)
Jan. 17, 2024
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Acquisitions                
Cash outflow, net of cash acquired             $ 542 $ 4,699
Payments of contingent consideration             3,236 0
Payments of deferred consideration             $ 35,398 $ 11,250
NGC                
Acquisitions                
Cash     $ 146          
Accounts receivable, net     2,487          
Prepaid expenses and other current assets     398          
Inventories, net     3,400          
Property, plant and equipment, net     10,858          
Right-of-use assets     2,842          
Goodwill     1,285          
Deferred tax liabilities     (265)          
Liabilities assumed     (12,966)          
Net assets acquired     23,773          
Consideration paid in cash, net of working capital adjustments     2,368          
Equity consideration     15,053          
Contingent consideration classified as a liability     6,352          
Total consideration     23,773          
Cash outflow, net of cash acquired     2,222          
Acquisition related contingent equity consideration (in shares) | shares   621,166            
Payments of contingent consideration   $ 3,200            
NGC | Licenses                
Acquisitions                
Intangible assets     15,387          
NGC | Trade names                
Acquisitions                
Intangible assets     $ 201          
Curaleaf Poland S.A.                
Acquisitions                
Cash       $ 48        
Accounts receivable, net       414        
Prepaid expenses and other current assets       2        
Inventories, net       661        
Property, plant and equipment, net       14        
Goodwill       931        
Deferred tax liabilities       (548)        
Liabilities assumed       (891)        
Net assets acquired       2,823        
Consideration paid in cash, net of working capital adjustments       832        
Equity consideration       773        
Contingent consideration classified as a liability       1,218        
Total consideration       2,823 € 1.5      
Cash outflow, net of cash acquired       784        
Acquisition related deferred equity consideration (in shares) | shares 96,052              
Payments of deferred consideration $ 400              
Curaleaf Poland S.A. | Licenses                
Acquisitions                
Intangible assets       2,063        
Curaleaf Poland S.A. | Trade names                
Acquisitions                
Intangible assets       97        
Curaleaf Poland S.A. | Non-compete agreements                
Acquisitions                
Intangible assets       $ 32        
Dark Heart                
Acquisitions                
Net assets acquired           $ 9,365    
Consideration paid in cash, net of working capital adjustments           1,693    
Cancelled loan (including accrued interest)           7,672    
Total consideration           9,365    
Dark Heart | Intellectual property and know-how                
Acquisitions                
Intangible assets           $ 9,365